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In Vitro Morphological Studies on Antibody- 
Dependent Nonimmune Lymphocyte- 
Mediated Cytotoxicity in Chronic Active 
Liver Disease 
HIDENORI KAWANISHI, MD 
Using an in vitro system of antibody-dependent cellular cytotoxicity (ADCC), the killing 
effect of chronic liver disease sera on target Chang cells, mediated by effector nonimmune 
lymphocytes (NLy), was studied. NLy destroyed Chang cells in monolayers pretreated 
with sera of patients with chronic active liver disease (CALD). Sera from these patients 
with CALD, after receiving steroid therapy, demonstrated a significant decrease of the 
cytotoxic action of NLy. The target cells treated with sera of normal subjects or patients 
with chronic persistent hepatitis were only minimally affected. Morphological observa- 
tions of the cytotoxic action in a CALD serum-treated group showed intimate contact 
between NLy and the target cells in the areas of the plaques, where large numbers of the 
target Chang cells were injured and were closely associated with effector NLy. The Chang 
cells developed cytoplasmic swelling. The surface became ruffled, and intracytoplasmic 
organelles displayed vesicular degeneration. Thereafter, cell rupture and fragmentation 
occurred. The sera in patients with CALD appear to possess a membrane reactive factor, 
presumably antibody, against the surface membrane of Chang cells. This immunological 
mode of reaction between the effectors and target cells (ADCC) may be important in the 
perpetuation and pathogenesis of hepatocyte death in CALD. 
There is evidence suggesting the participation of 
both cellular and humoral immune processes in the 
liver of patients with chronic active liver disease 
(CALD) (1-12). The autoimmune phenomena seem 
to be responsible for hepatocyte injury in that pri- 
mary immune reactivity appears to be directed 
against liver tissue constituents in the presence of 
specific autoantibodies. Liver-specific protein anti- 
gens, associated with the cell membrane of hepato- 
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cytes (13) and cytoplasmic organelles (13, 14), have 
been characterized and, using some of these anti- 
gens, autoimmune chronic active hepatitis has been 
produced in rabbits (6). Self-directed antibodies, 
such as anti-liver-specific lipoprotein antibodies (2), 
and liver-specific antigens, such as F-antigen (14), 
are often present in the sera of patients with CALD. 
In our previous study (11), using liver biopsy speci- 
mens from patients with chronic liver disease, the 
close morphological association of lymphocytes 
with hepatocyte injury was found in CALD. 
One possible mechanism for the induction of tar- 
get liver parenchymal cell injury or death in CALD, 
involving both cell-mediated and humoral immune 
systems,  is an t ibody-dependent  cellular cy- 
totoxicity (ADCC), which has been extensively 
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studied in various animal and other human experi- 
mental models (15-26). This immune mechanism is 
characterized by the killing of antibody-coated tar- 
get cells by NLy.  No complement is required for 
this target cell lysis. 
The present study is, therefore, an attempt to in- 
vestigate an in vitro ADCC in the immune patho- 
genesis of CALD.  We have particularly focused on 
demonstrating similar morphological interrelation 
in vitro, as seen in liver tissues of patients with 
CALD,  between effector lymphocytes  and target 
Chang cells sensitized by C A L D  sera, which pre- 
sumably contain anti-liver cell-surface antibody. 
MATERIALS AND METHODS 
Sera. All aera studied were obtained from 10 normal 
healthy individuals, 7 patients with chronic persistent 
hepatitis (CPH), and 9 patients with chronic active liver 
disease (CALD) before prednisone therapy. Post-steroid- 
treated sera of the patients with CALD were also used. 
These specimens were inactivated at 56 ~ C for 30 min, 
followed by absorption with minced and lyophilized hu- 
man cadaveric kidney tissues (less than 6 hr postmortem) 
at 37 ~ C for 60 min and subsequently overnight at 4 ~ C. 
The treated test and control sera were then stored at 
-20  ~ C before use. The diagnosis of patients with chronic 
liver disease (CPH and CALD) were established on the 
basis of clinical, biochemical, and histological data (27). 
The CALD patients, treated with prednisone, were all in 
good clinical and biochemical control, as assessed by the 
criteria of the Mayo group (27). 
Target Cells. The target cells used in this study were a 
human liver cell strain of Chang, purchased from Micro- 
biological Associates, Bethesda, Maryland. 
Effector Lymphocytes. Venous peripheral lymphocytes 
from normal individuals ranging from 18 to 41 years of age 
were separated by dextran and Ficoll-Hypaque gradi- 
ents (28). Contaminating monocytes were removed by 
adhesiveness to plastic tissue culture wells in a moistur- 
ized atmosphere (95% air-5% COs) at 37 ~ C for 2 hr. More 
than 98% of the recovered cells were lymphocytes, which 
were differentiated by Wright-stain smears, and per- 
oxidase stain (29) for monocytes. The lymphocytes had 
greater than 95% viability as assessed by trypan blue dye 
(0.05%) exclusion. The cells were washed 3 times with 
Hank's balanced salt solution (HBSS) before being added 
to the test system. 
In Vitro ADCC Test System. The methods used are a 
modification of those described by Biberfeld et al (30). 
Approximately 3 x 104 Chang target cells were first 
grown in a 35 x 10-mm Falcone tissue culture well 
(#3001) with 2.5 ml of 80% Eagle's Minimal Essential 
Medium (MEM)-20% heat-inactivated fetal calf serum 
(56 ~ C, 30 rain) (FCS) supplemented with L-glutamine (2 
mM/ml) and antibiotics (100 units of penicillin and 100 p,g 
of streptomycin/ml) at 37 ~ C in a moist atmosphere of 
95% air and 5% COg. The monolayers were obtained after 
72 hr incubation. Each culture dish was washed 3 times 
with HBSS to eliminate dead cells and cell debris. The 
Chang cells in monolayer were treated with 1 ml of each 
test or control serum, diluted to 10 -e with Eagle's MEM, 
or 1 ml of the latter nutrient medium alone, for 60 min 
under the above conditions. Our previous observation by 
immunofluorescence showed that membrane-fixed IgG in 
the sera from patients with CALD was weakly detected 
on Chang cells up to a dilution of 10 -2 (31). All CALD 
sera tested contained anti-human and -rabbit hepatocyte 
surface membrane antibodies (IgG), which were shown 
also by immunofluorescence (32). Thereafter, the culture 
dishes were thoroughly washed 5 times using HBSS. Cul- 
ture medium, 1.5 ml, consisting of 90% Eagle's MEM- 
10% FCS with L-glutamine and the antibiotics, was added 
to each well. Then 2 • 106 lymphocytes in 0.05 ml of the 
culture medium were placed over the central part of the 
monolayers. Approximate estimation of a ratio of the ef- 
fector cell to target cell was at 10:1 within the plaque 
area (33). 
The cultures were maintained in water-saturated 5% 
CO2 in air at 37 ~ C for 72 hr. Each experiment was per- 
formed in duplicate. At the termination of each culture, 
the following studies were carried out: 
LDH (Lactic Dehydrogenase) Determination. LDH ac- 
tivity of the supernatant from each culture medium was 
measured, using a centrifugal analyzer (LDH-L, Smith 
Kline Instruments, Inc., Palo Alto, California) (34). 
The Wilcoxon rank sum test was used for statistical 
analysis. 
Plaque Formation (PF). PF in the central areas of the 
monolayers, treated as described, was estimated accord- 
ing to the scale shown in Figure i. 
Morphological Observations. Target cell killing by NLy 
was followed at daily intervals with a phase-contrast in- 
verted microscope. The cultures of ADCC test systems 
were also made on 2.8-mm round coverslips in quadrupli- 
cate. The duplicate coverslips were fixed in 95% alcohol, 
and stained with Wright's solution. For scanning electron 
microscopy, the cells grown on the remaining coverslips 
(duplicate) were rinsed twice with phosphate-buffered sa- 
line solution (PBS) (pH7.4), and then fixed, using 2% 
glutaraldehyde in 0.1 M cacodylate buffer. The fixed 
specimens were dehydrated through graded ethanol, 
followed by 2 washes of 100% amyl acetate and CO2 criti- 
cal-point drying (35). After coating with gold of approxi- 
mately 100 A, they were examined in a JSM-U3 scanning 
electron microscope at a beam voltage of 20 kV. For 
transmission electron microscopy, the cultured cells were 
fixed in situ with the cacodylate-buffered glutaraldehyde. 
The culture media were used for determination of the ac- 
tivity of LDH (see above). After postfixation in 1% OsO4 
and dehydration, the cells were detached from the dish- 
es (36) and embedded in Epon. Sections 1 ~m thick 
stained with i% toluidine blue were used for orientation. 
Thin sections of the specimens were examined in a Hi- 
tachi HU-11C-1 electron microscope. 
RESULTS 
LDH Assay. Table 1 shows the LDH levels in cul- 
ture media from the various experiments. There 
was a significant increase of LDH activity in cul- 
tures with N L y  and Chang monolayer  cells (no se- 
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TABLE 1. ANTIBODY-DEPENDENT CELLULAR (LYMPHOCYTE) CYTOTOXICITY, ESTIMATED BY L D H  ASSAY AND PLAQUE FORMATION 
(PF)--CULTURES OF 3 DAYS 
Experiments 
Source of serum used for 
Types of cells pretreatment of target Number of LDH* 
in culture Chang cells samples (IU/ml + 1 SD) PF? 
Chang  cells None  10 98.8 -+ 8.6 0 
N o n i m m u n e  lymphocy tes  (NLy)  None  10 29.5 -+ 3.2 0 
Chang cells + N L y  None  10 152.6 -+ 10.6 0 to 1 + 
Chang cells Normal  serum 10 104.7 _+ 5.0 0 
Chang cells + N L y  Normal  serum 10 156.5 -+ 8.3 0 to 1 + 
Chang cells CPH serum 7 102.6 -+ 5.9 0 
Chang cells + N L y  CPH serum 7 153.0 -+ 9.0 0 to 1 + 
Chang cells C A L D  serum 9 104.1 -+ 9.3 0 
Chang cells + N L y  C A L D  serum 9 242.8 + 32.1 2+  to 3+  
Chang cells Steroid-treated C A L D  9 106.0 -+ 15.4 0 
Chang cells + N L y  Steroid-treated C A L D  9 172.6 _+ 26.1 0 to 2+  
*Statistical analysis:  see text. 
tScor ing  o f  PF (0 to 3 +): see Figure 1. 
rum treatment) (P < 0.001) compared with cultures 
of either cell type alone. Treatment with control or 
test sera alone did not induce cytotoxicity in Chang 
cells. However,  LDH activity in the media in- 
creased if Chang cells, pretreated with CALD sera, 
were exposed to NLy (P < 0.001). In the steroid- 
treated patients with CALD, the LDH values de- 
creased (P < 0.00I), compared with the nontreated 
patients, but remained greater than those of the N 
and CPH groups (0.01 < P < 0.05). 
PF. The degree of central clearance of the mono- 
layers of Chang cells at the sites covered by NLy 
are shown in Figure 1. Small plaques (H) were often 
demonstrated in the cultures of NLy with Chang 
cells, whether non-precoated or precoated with N 
or CPH sera (Table 1). Enhancement of PF was ob- 
served in Chang cells pretreated with CALD sera in 
the presence of NLy (Table 1). The PF became evi- 
dent on the second day of incubation and had in- 
creased by the third day. 
Morphological Interaction between Effector NLy 
and Target Chang Cells. Examination of unstained 
phase-contrast and stained specimens indicated 
close cell-to-cell contact of these two cell types, but 
only in areas of developing plaques, as shown in 
Figure 2. There were many rosettes, formed by the 
effector and target cells (Figure 2b,c). The target 
cells surrounded by these NLy began to swell and 
become round with increased intracytoplasmic ve- 
sicular inclusions (Figure 2c). Thereafter, the cells 
became detached. In contrast, most of the attached 
target cells not exposed to NLy did not display cy- 
topathic changes. Epon-embedded thick survey 
sections permitted examination of the structural 
relationships of these effector and target Chang 
cells by sectioning vertically to the plane of the 
monolayer (Figure 3a-d). Following exposure of 
Chang cells to sera from patients with CALD, NLy 
established contact with the surface of the target 
cells by many small cell membrane projections 
(pseudopods) (Figure 3a). NLy often migrated into 
the intercellular space between two target cells 
(Figure 3b). The Chang cells adhering to NLy ap- 
peared swollen and rounded, while some had rup- 
tured (Figure 3d). 
Scanning electron microscopic observation dem- 
onstrated that a few small or medium-sized lympho- 
cytes often adhered to one or several elongated cy- 
toplasmic projections of Chang cells pretreated with 
CALD sera on the culture coverslip (Figure 4b). 
The surface appearance of NLy was either hairy or 
smooth (Figure 4b-d). These Chang cells reacting 
with NLy displayed swollen and rounded cellular 
contours with many cytoplasmic ruffled buddings 
on the surface (Figures 4b,c). Microvilli on the sur- 
face disappeared as seen in intact Chang cells (Fig- 
ure 4a). The cell membrane of the degenerating tar- 
get cells in close association with NLy had dis- 
integrated further and finally fragmented and 
ruptured (Figure 4d). In transmission electron mi- 
croscopy, NLy again formed direct contact with the 
surface microvilli  of  the CALD serum-t rea ted  
Chang cells by the minute projections of the ef- 
fector lymphocytes. These NLy had the appearance 
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Fig 1. Plaque formation (PF) in monolayers of control or test serum-precoated Chang cells induced by nonimmune lymphocytes (after 
washing with HBSS): (a) CPH serum-treated culture; (b) normal serum-treated culture, (c) CALD serum-treated culture, and (d) 
CALD serum-treated culture, demonstrating 0, +, + +, and + + + PF, respectively. Note prominent adherence of lymphocytes in the 
overlayed central part of culture (d), as seen by a denser zone even after washing. 
Fig 2. (facing page) Light micrographs of the interaction between effector nonimmune lymphocytes and Chang cells in the presence of 
test sera (CPH and CALD): (a) Treatment with CPH serum, not showing cytotoxicity of the target cells (Wright stain, x350), (b) 
treatment with CALD serum, showing adherence of lymphocytes to remaining Chang cells at the site of PF (Wright stain, x 340), (c) 
treatment with CALD serum, displaying a few lymphocytes attaching to a swollen and injured Chang cell (C); note abundant intra- 
cytoplasmic vesicular inclusions. (phase contrast, x 1080) 
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Fig 3. Light micrographs of epon-embedded thick sections of Chang cell 
monolayers treated with CALD serum: (a) two small lymphocytes (L) 
contacting a Chang cell by means of multiple cytoplasmic projections of 
the effectors. A detached swollen Chang cell is seen with marked injury 
(C). (b) A small lymphocyte (L), infiltrating between two Chang cells. 
(c) A degenerating rounded Chang cell (C), which appears to be contacted 
by surface minute processes of a lymphocyte. Note a lymphocyte (L) 
adhering to a Chang monolayer cell. (d) A rupturing and fragmenting Chang 
cell (C). A lymphocyte (L) is in contact with the dying cell. (toluidine 
blue stain, x 1400) 
of a nondividing nuclear pattern with well-devel- 
oped organelles and frequently increased lysosomal 
elements (Figures 5a,b). There was no morphologi- 
cal evidence of blast transformation of the NLy nor 
evidence of a NLy entering the Chang cell (emper- 
ipolesis) (37). Cytoplasmic swelling, and vesicula- 
tion of intracellular organelles, appeared to precede 
target cell fragmentation. Study of the detached 
Chang cells in the supernatant indicated that the 
majority of these cells were severely damaged or 
dead with cytoplasmic vesicovacuolation (Figure 
6). 
In cultures incubated without serum or with nor- 
mal sera or sera from patients with CPH, the above- 
mentioned observations were much less frequent or 
absent (Figures 2a, 4a). 
DISCUSSION 
The in vitro destruction of antibody-coated target 
cells by NLy (ADCC) has been described in many 
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experimental systems, including cytolysis of red 
cells (16, 19), allogeneic (22) and autologous lym- 
phocytes (23), allogeneic leukemic cells (24), and 
various human tissue culture cells (17, 18, 25, 26). 
This report appears to describe an in vitro model for 
the ADCC of CALD. The elevation of LDH levels 
and PF in cultures of Chang cells, pretreated with 
CALD sera in the presence of NLy, correlates with 
cytological observations of target Chang cell death. 
Chang cells, which were used as target cells here, 
were first introduced in 1954 as an epithelial-like hu- 
man adult liver cell line (38). This cell line has been 
utilized for studies of the cellular immune response, 
including immune cytotoxicity assays in acute and 
chronic hepatitis (8, 9, 30, 31, 33). However, the 
validity of use of Chang target cells as models of 
human hepatocytes has recently been questioned 
because of similarity of isoenzyme patterns and 
chromosomal characteristics between Chang cells 
and HeLa cells (39). Chang cells from the same 
source (American Type Culture Collection) as those 
in the latter study, however, have been found to 
synthesize human albumin, fibrinogen, transferrin, 
alphaz macroglobulin, beta1 lipoprotein and C'3 
complement (40). HeLa cells not only fail to com- 
plete these functions but are also morphologically 
different from Chang cells (40). Interestingly, lym- 
phocytes from patients with acute and chronic ac- 
tive hepatitis can cause significant lysis of not only 
autologous human liver cells, but also Chang cells 
in vitro (8, 9). Thus, Chang cells seem to have many 
characteristics in common with liver parenchymal 
cells. To verify the use of Chang cells as human he- 
patocytes in in vitro immunological studies an anti- 
gen characterization of the surface membrane of the 
former cells is further required. 
In the experiments reported here, NLy alone 
caused minimal lysis of nontreated Chang cells. 
This nonspecific cytodestruction may be due to HL- 
A incompatibility (41) or to spontaneous lympho- 
cyte-mediated cytotoxicity, as is demonstrated in 
other in vitro systems (42). 
Cytolysis of CALD serum-treated Chang cells 
was significantly enhanced by NLy. This finding is 
in contrast to the lack of enhancement of cytolysis 
of Chang cells treated with normal or CPH sera. 
This enhancement of target lysis appears to indicate 
that the sera from patients with CALD reacts with 
the surface membrane antigens of the Chang cells 
and that the antigen-antibody complexes may acti- 
vate  N L y  with resul tant  killing of the target  
cells (30). It has previously been demonstrated that 
the CALD sera, absorbed with Chang cells or hu- 
man adult liver cells failed to induce target Chang 
cell destruction in vitro, determined by a micro- 
cytotoxicity assay in the ADCC similar to the pres- 
ent system (31). This evidence seems to suggest the 
p resence  of immunological  c ross- reac t iv i ty  be- 
tween Chang cells and human liver cells at least to 
some extent. However, because of the questionable 
identity of the Chang target cells as human hepato- 
cytes, the reactive antibody on the surface of Chang 
cells in the test sera of CALD might be associated 
with new antigens of modified cell membrane pro- 
tein of human liver parenchymal cells, produced by 
hepati t is  viruses (10) or unknown hepa to tox ic  
agents. The antibody may, therefore, cross-react 
between two cell types in certain pathological con- 
ditions, like CALD. On the other hand, it cannot be 
entirely excluded in the present experiments that 
the toxic effect of normal lymphocytes in the pres- 
ence of the antibodies on the target cells may be 
nonspecific, since target cells other than Chang 
cells were not tested. 
The reduction of cytotoxicity by NLy when ster- 
oid-treated CALD sera were used in the same 
patients studied before the treatment may be ex- 
plained by a decrease of anti-target-cell membrane 
antibody in the test sera and subsequent inhibition 
of lymphocyte activation by contact with the target 
cells (43). This hypothesis will be proved by mea- 
suring the antibody titers of each CALD serum test- 
ed, which was not done in the present study. What- 
ever the mechanism is, even in CALD cases receiv- 
ing steroids, some immune target cytodestruction 
by ADCC persists. 
NLy, adhering to the target Chang cells pre- 
coated by CALD sera, display features of active 
movement, as suggested by infiltration of the Chang 
cell monolayers. The increased motility of NLy 
may be caused by their interaction with antigen-an- 
t ibody complexes  on the surface of  the target  
cells (41). The presence of multiple pseudopods in 
the active NLy may provide further evidence of 
their functional activation. However, the absence 
of uropods, frequently present in lymphocytes stim- 
ulated by PHA or Con A (15) and in a similar ADCC 
model in vitro (30), suggests that the NLy activa- 
tion may be less extensive. As in the other reports 
on ADCC (15-18, 41), the cytotoxic action of NLy 
does not require complement, and these lympho- 
cytes show neither blast transformation nor phago- 
cytic activity during target cell lysis. 
The effector lymphocytes participating in ADCC 
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Fig. 4A. Scanning electron micrograph demonstrating 
cytopathic effect of lymphocytes on Chang cells. A 
normal serum-precoated Chang cell monolayer with 
lymphocytes (L). Note no destruction of the Chang 
cells. (x 1300) 
Fig 4B. Scanning electron micrograph demonstrating 
cytopathic effect of lymphocytes on Chang cells. 
A CALD serum-treated Chang cell (C), injured by 
adherence of hairy and smooth-surfaced lymphocytes 
on long cytoplasmic processes of the former cell. The 
Chang ceils are swollen and rounded in association 
with ruffled cell surface. (x3250) 
104 Digestive Diseases, Vol. 23, No. 2 (February 1978) 
A D C C  IN C H R O N I C  L I V E R  D I S E A S E  
Fig 4C. Scanning electron micrograph demor~strating 
cytopathic effect of lymphocytes on Chang cells. A 
CALD serum-treated Chang cell (C) in intimate con- 
tact with a hairy lymphocyte, which appears to ele- 
vate some of the foot processes of the former cell. 
The surface of the Chang cell exhibits multiple cy- 
toplasmic budding. (x 10,400) 
Fig 4D. Scanning electron micrograph demonstrating 
cytopathic effect of lymphocytes on Chang cells. A 
markedly damaged and ruptured Chang cell (C), pre- 
treated with CALD serum. Two lymphocytes are still 
adhering to the target cell. Many fragmented cellular 
components of various sizes are seen on and around 
the Chang cell. (x4380) 
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Fig 5. Transmission electron micrographs of cultures, treated with CALD sera. (a) A small lymphocyte 
(L) migrating into an intercellular space between two Chang cells. There are well-developed cytoplasmic 
organelles. Note some increase in lysosomes (Is). The lymphocyte is attached to a Chang cell via micro- 
villous structures of the latter (arrowheads). (x20,400) (b) A small lymphocyte (L) adhering to a Chang 
cell through surface microprojections of the former cell (arrowheads). (x20,400) 
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Fig 6. Transmission electron micrograph of two rupturing and swollen dead Chang cells (C) in the super- 
natant of CALD serum-treated culture medium, suggestive of osmolysis (x8400) 
have been characterized as possessing Fc receptors 
on the surface membrane, lacking the ability to 
form both sheep red cell rosettes and devoid of de- 
tectable membrane Igs (44). At present, it seems 
likely that the major effectors of NLy in the system 
of ADCC are null cells and their proge- 
ny (20, 21, 23). 
The morphological evidence of Chang cell lysis 
mediated by NLy in the in vitro system exhibits 
great similarity to our previous observation (11), 
which showed the close association of lymphocytes 
with hepatocyte death via cell-to-cell contact in the 
liver of CALD in vivo. The present studies suggest 
that the intimate surface attachment between the ef- 
fector NLy and target Chang cells pretreated with 
CALD sera may initiate the cytolysis of the latter 
cells. The subsequent sequence of destruction of 
Chang cells (swelling with ruffled surface, then rup- 
ture and fragmentation) is similar to that described 
by Biberfeld et al (30), who demons t ra ted  cy- 
topathological changes in Chang cells in the pres- 
ence of anti-Chang cell serum when these target 
cells were exposed to NLy. This was suggested to 
be due to osmotic lysis. Humoral factors, released 
from activated lymphocytes at the sites of effector 
target cell contact, may be involved in the target 
cell death (30). 
In conclusion, our studies show that target Chang 
cell lysis was initiated by direct contact with ef- 
fector NLy in the presence of CALD sera, the latter 
probably containing antibodies against Chang cell- 
surface membrane antigens. As described above, 
the antibodies in sera from CALD patients may 
cross-react with Chang cells and human hepato- 
cytes under certain abnormal conditions. The target 
cells appear to exhibit an osmotic lysis preceded by 
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swelling and rupture .  The in vi tro target  cy- 
todestruction may be a useful model for the study of 
hepatocyte injury in CALD. 
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